Glenn Saldanha of Glenmark appointed IPA President
New Delhi: Indian Pharmaceutical Alliance (IPA), a body of major domestic pharma firms, said Glenn Saldanha has been appointed as President for 2017-19.
Saldanha is Chairman & Managing Director of Glenmark Pharmaceuticals.
IPA also appointed Panacea Biotec Joint Managing Director Rajesh Jain as Vice President.
The IPA, initially formed by eight national companies in November 1999, has now 20 research-based national pharmaceutical companies in its fold.
Some of the prominent members include Lupin, Cadila Healthcare, Cipla, Dr. Reddy's Laboratories and Sun Pharmaceutical Industries among others.